Risk factors for EUS-guided radiofrequency ablation adverse events in patients with pancreatic neoplasms: a large national French study (RAFPAN study)
Bertrand Napoléon, Andrea Lisotti, Fabrice Caillol, Mohamed Gasmi, Philippe Ah‐Soune, Arthur Belle, Antoine Charachon, Franck Cholet, Pierre-Yves Eyraud, Philippe Grandval, Jean‐Michel Gonzalez, François Habersetzer, Stéphane Koch, Marc Le Rhun, Luigi Mangialavori, Nicolas Musquer, Maxime Palazzo, Laurent Poincloux, Jocelyn Privat, Adrien Sportes, Morgane Stouvenot, C. Subtil, Lucie Thomassin, Geoffroy Vanbiervliet, Guillaume Vidal, Lucine Vuitton, Marc Giovannini, Marc Barthet
Topics & Concepts
MedicineOdds ratioRadiofrequency ablationAdverse effectPancreasPancreatic ductIntraductal papillary mucinous neoplasmConfidence intervalInternal medicineUnivariate analysisGastroenterologyMultivariate analysisRadiologyRetrospective cohort studyAblationPancreatic and Hepatic Oncology ResearchCholangiocarcinoma and Gallbladder Cancer StudiesNeuroendocrine Tumor Research Advances